Taking the drug osimertinib once a day after surgery reduces chance of patients dying by 51%, trials show
A pill taken once a day cuts the risk of dying from lung cancer by half, according to “thrilling” and “unprecedented” results from a decade-long global study.
Taking the drug osimertinib after surgery dramatically reduced the risk of patients dying by 51%, results presented at the world’s largest cancer conference showed.
More Stories
Poorer children more likely to age faster than affluent counterparts, study finds
Cancer experts warn of coffee enemas and juice diets amid rise in misinformation
Elon Musk shows he still has the White House’s ear on Trump’s Middle East trip